Note 3 - Significant Accounting Policies - Recasted Financial Statements (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Thousands |
12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2017
USD ($)
$ / shares
|
Dec. 31, 2016
USD ($)
$ / shares
|
Dec. 31, 2016
CAD ($)
$ / shares
|
Dec. 31, 2015
USD ($)
$ / shares
|
Dec. 31, 2015
CAD ($)
$ / shares
|
Dec. 31, 2016
CAD ($)
|
Jan. 01, 2016
USD ($)
|
Jan. 01, 2016
CAD ($)
|
Dec. 31, 2014
USD ($)
|
|
Current assets: | |||||||||
Cash and cash equivalents | $ 10,631 | $ 7,940 | $ 8,311 | $ 10,662 | $ 8,311 | $ 11,503 | $ 12,383 | ||
Investments | 798 | 5,957 | 8,245 | ||||||
Prepaid expenses and other assets | 396 | 493 | 663 | 771 | 1,067 | ||||
Total current assets | 11,825 | 8,433 | 11,325 | 15,039 | 20,815 | ||||
Non-current assets: | |||||||||
Equipment and intangibles | 213 | 285 | 314 | 434 | |||||
Total non-current assets | 142 | 213 | 285 | 314 | 434 | ||||
Total assets | 11,967 | 8,646 | 11,610 | 15,353 | 21,249 | ||||
Current liabilities: | |||||||||
Accounts payable and accrued liabilities | 1,765 | 1,318 | 1,770 | 1,702 | 2,356 | ||||
Total current liabilities | 1,765 | 1,318 | 1,770 | 1,702 | 2,356 | ||||
Shareholders’ equity: | |||||||||
Common shares | 231,923 | 218,034 | 230,976 | 212,308 | 223,425 | ||||
Stock options | 6,456 | 7,306 | 8,133 | 5,740 | 6,256 | ||||
Contributed surplus | 22,909 | 21,413 | 22,267 | 21,188 | 22,037 | ||||
Warrants | 85 | 84 | |||||||
Accumulated other comprehensive loss | (4,298) | (4,298) | (4,783) | ||||||
Deficit | (246,788) | (235,127) | (251,536) | (220,887) | (232,909) | ||||
Total shareholders’ equity | 10,202 | 7,328 | 13,651 | 9,840 | 13,651 | 18,893 | $ 25,233 | ||
Total liabilities and shareholders’ equity | 11,967 | 8,646 | $ 11,610 | $ 15,353 | $ 21,249 | ||||
Revenue | |||||||||
Expenses: | |||||||||
Research and development | 6,274 | 7,834 | 10,322 | 4,865 | 6,254 | ||||
General and administrative | 5,552 | 6,439 | 8,344 | 7,992 | 9,845 | ||||
11,826 | 14,273 | 18,666 | 12,857 | 16,099 | |||||
Finance expense | 46 | 66 | 34 | 43 | |||||
Finance income | (165) | (79) | (105) | (1,180) | (1,516) | ||||
Net finance (income) expense | (165) | (33) | (39) | (1,146) | (1,473) | ||||
Net loss for the year | (11,661) | (14,240) | (18,627) | (11,711) | (14,626) | ||||
Foreign currency translation gain (loss) | 485 | (3,519) | |||||||
Comprehensive loss for the year | $ (11,661) | $ (13,755) | $ (18,627) | $ (15,230) | $ (14,626) | ||||
Basic and diluted loss per common share (in CAD per share) | (per share) | $ (0.52) | $ (1.12) | $ (1.46) | $ (0.98) | $ (1.23) |
X | ||||||||||
- Definition Carrying value of equipment and intangibles. No definition available.
|
X | ||||||||||
- Definition A component of equity resulting from warrants. No definition available.
|
X | ||||||||||
- Definition The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of resources: (a) controlled by the entity as a result of past events; and (b) from which future economic benefits are expected to flow to the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of earnings per share when the basic and diluted measurements are equal. [Refer: Basic earnings (loss) per share; Diluted earnings (loss) per share] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of current held-to-maturity investments. [Refer: Held-to-maturity investments] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of costs associated with financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of income associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of income or cost associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of expense relating to general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The nominal value of capital issued. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The amount of assets that do not meet the definition of current assets. [Refer: Current assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The amount of all operating expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The total of income less expenses, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition A component of equity resulting from share-based payments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition A component of equity representing the entity's cumulative undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in economic benefits during the accounting period in the form of inflows or enhancements of assets or decreases of liabilities that result in an increase in equity, other than those relating to contributions from equity participants. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|